ASLN - アスラン・ファ―マシュ―ティカルズ （ASLAN Pharmaceuticals Limited） アスラン・ファ―マシュ―ティカルズASLNのチャート
ASLNの企業情報
| symbol | ASLN |
|---|---|
| 会社名 | ASLAN Pharmaceuticals Ltd （アスラン・ファ―マシュ―ティカルズ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Major Pharmaceuticals |
| 業種 | ― 医療関連（Health Care） |
| 概要 | 事業概要 -- アスラン・ファ―マシュ―ティカルズはケイマン諸島籍のバイオ医薬品メ―カ―。臨床段階で腫瘍学を中心に、アジアで一般的な疾病や、欧米での希少疾病を対象とした治療薬の開発を手掛ける。胆道がん、胃がん、乳がん、結腸直腸がん、急性骨髄性白血病、喘息、アトピ―性皮膚炎などの候補薬を保有する。台湾、オ―ストラリア、中国に事務所を置く。本社所在地はシンガポ―ル。 Aslan Pharmaceuticals Ltd. is a clinical-stage oncology-focused biopharmaceutical company, which engages in the development of novel therapeutics. Its pipeline includes varlitinib, ASLAN003, ASLAN004, and ASLAN002. The firm's portfolio focuses on validated growth pathways applied to new patient segments, novel immune checkpoints, and novel cancer metabolic pathways. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale, and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. |
| 本社所在地 | 190 Elgin Avenue George Town Grand Cayman KY1-9005 CYM |
| 代表者氏名 | ― |
| 代表者役職名 | ― |
| 電話番号 | ― |
| 設立年月日 | 41791 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2018年 |
| 従業員数 | 38人 |
| url | www.aslanpharma.com |
| nasdaq_url | https://www.nasdaq.com/symbol/asln |
| adr_tso | 6000000 |
| EBITDA | EBITDA ー |
| 終値（lastsale） | 7.32 |
| 時価総額（marketcap） | 43920000 |
| 時価総額 | 時価総額 ― |
| 売上高 | 売上高 -- |
| 企業価値(EV) | 企業価値(EV) ー |
| 当期純利益 | 当期純利益 -- |
| 決算概要 | 決算概要 -- |
ASLNのテクニカル分析
ASLNのニュース
ASLAN Pharmaceuticals : reports second quarter 2020 financial results and provides corporate update | MarketScreener 2020/07/13 10:56:07 MarketScreener
ASLAN Pharmaceuticals reports second quarter 2020 financial results and provides corporate update ASLAN Pharmaceuticals today announced financial results for the… | July 13, 2020
ASLAN Pharmaceuticals Ltd. (ASLN) Dips More Than Broader Markets: What You Should Know 2020/02/20 22:50:17 Zacks Investment Research
ASLAN Pharmaceuticals Ltd. (ASLN) closed the most recent trading day at $2.10, moving -1.87% from the previous trading session.
ASLAN Pharmaceuticals Ltd. (ASLN) Stock Sinks As Market Gains: What You Should Know 2020/02/10 22:45:20 Zacks Investment Research
ASLAN Pharmaceuticals Ltd. (ASLN) closed at $2.11 in the latest trading session, marking a -0.94% move from the prior day.
ASLAN Pharmaceuticals Ltd. (ASLN) Gains But Lags Market: What You Should Know 2020/02/04 22:45:17 Zacks Investment Research
ASLAN Pharmaceuticals Ltd. (ASLN) closed the most recent trading day at $2.17, moving +0.93% from the previous trading session.
Has ASLAN Pharmaceuticals (ASLN) Outpaced Other Medical Stocks This Year? 2020/01/27 16:30:18 Zacks Investment Research
Is (ASLN) Outperforming Other Medical Stocks This Year?
ASLAN Pharmaceuticals : reports second quarter 2020 financial results and provides corporate update | MarketScreener 2020/07/13 10:56:07 MarketScreener
ASLAN Pharmaceuticals reports second quarter 2020 financial results and provides corporate update ASLAN Pharmaceuticals today announced financial results for the… | July 13, 2020
ASLAN Pharmaceuticals Ltd. (ASLN) Dips More Than Broader Markets: What You Should Know 2020/02/20 22:50:17 Zacks Investment Research
ASLAN Pharmaceuticals Ltd. (ASLN) closed the most recent trading day at $2.10, moving -1.87% from the previous trading session.
ASLAN Pharmaceuticals Ltd. (ASLN) Stock Sinks As Market Gains: What You Should Know 2020/02/10 22:45:20 Zacks Investment Research
ASLAN Pharmaceuticals Ltd. (ASLN) closed at $2.11 in the latest trading session, marking a -0.94% move from the prior day.
ASLAN Pharmaceuticals Ltd. (ASLN) Gains But Lags Market: What You Should Know 2020/02/04 22:45:17 Zacks Investment Research
ASLAN Pharmaceuticals Ltd. (ASLN) closed the most recent trading day at $2.17, moving +0.93% from the previous trading session.
Has ASLAN Pharmaceuticals (ASLN) Outpaced Other Medical Stocks This Year? 2020/01/27 16:30:18 Zacks Investment Research
Is (ASLN) Outperforming Other Medical Stocks This Year?
ASLAN Pharmaceuticals : reports second quarter 2020 financial results and provides corporate update | MarketScreener 2020/07/13 10:56:07 MarketScreener
ASLAN Pharmaceuticals reports second quarter 2020 financial results and provides corporate update ASLAN Pharmaceuticals today announced financial results for the… | July 13, 2020
ASLAN Pharmaceuticals Ltd. (ASLN) Dips More Than Broader Markets: What You Should Know 2020/02/20 22:50:17 Zacks Investment Research
ASLAN Pharmaceuticals Ltd. (ASLN) closed the most recent trading day at $2.10, moving -1.87% from the previous trading session.
ASLAN Pharmaceuticals Ltd. (ASLN) Stock Sinks As Market Gains: What You Should Know 2020/02/10 22:45:20 Zacks Investment Research
ASLAN Pharmaceuticals Ltd. (ASLN) closed at $2.11 in the latest trading session, marking a -0.94% move from the prior day.